2025年世界肾脏病学大会(WCN)

◆ 会议时间：2025年2月6-9日
◆ 会议地点：印度新德里

◆ 会议简介：

2025年国际肾脏病学会(ISN)世界肾脏病大会(ISN WCN 2025)将于2025年2月6-9日在印度新德里举行。世界肾脏病大会(WCN)汇聚了数千名世界肾脏保健领域的顶尖专家，介绍最新的进展，交流最新的科学，讨论最新的临床应用，旨在改善肾脏健康和预防肾脏疾病。本次会议由国际肾脏病学会(ISN)组织，阿根廷肾脏病学会(SAN)、拉丁美洲肾脏病和高血压学会(SLANH)联合举办。

ISN世界肾脏病学大会(WCN)是首屈一指的国际肾脏病学教育活动，原每两年在各大洲间轮流举办一次，由ISN与当地和地区的肾脏病学协会合作举办，自2019年之后改为每年举办一次；大会针对的是国际肾脏病学界以及其他从事多学科肾脏护理的医疗专业人员。WCN使来自世界各地的专业人士能够就与肾脏病学相关的各种主题交换意见，并支持ISN的使命，即建立一个所有人都能公平获得可持续肾脏健康的未来。

国际肾脏病学会（ISN）成立于1960年，是致力于促进全球肾脏健康的慈善组织，现在全球152个国家和地区拥有超过10000名专业成员。ISN的使命是通过教育宣和培训在全球范围内促进可持续性的肾脏健康。ISN代表着广泛的国际交流网络，并为世界各地的医疗保健专业人士间进行及时的科学交流、讨论、传播提供了一个高效的平台。此外ISN还与全球90多个国家与地区的肾脏病学协会密切合作，额外连接着30000余名专业人士。ISN的总体目标是应对急性肾损伤(AKI)、慢性肾脏病(CKD）和终末期肾脏病(ESKD)的全球负担，通过相互关联的宣传、教育和研究策略改善患者护理。ISN还致力于解决发展中国家与发达国家在肾脏病的研究、诊断、治疗和预防方面的差距。ISN通过会员、出版物、会议、项目以及世界肾脏日等形式，努力推动全球肾脏病学的发展。ISN自2019年开始在世界不同的地区举办国际肾脏病学界领先的教育活动——世界肾脏病大会（WCN）。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

World Congress of Nephrology (WCN 2025)

Dates:
February 6 – 9, 2025

Venue:
YASHOBHOOMI (India International Convention & Expo Centre)
Dwarka, New Delhi, India

Organized by :
International Society of Nephrology (ISN)

Hosted by：
Indian Society Of Nephrology

The World Congress of Nephrology:

A global event to advance your career and worldwide kidney health

The World Congress of Nephrology (WCN) is the annual scientific, educational, and networking meeting of the International Society of Nephrology. The WCN features regionally-relevant symposia, presentations, training programs, and courses, offering the latest science and state-of-the-art education in nephrology.

In line with the ISN’s core values, WCN’25 promotes equitable access and inclusivity.

摘要征文投稿：

Abstract submission opens: June 24, 2024

Submission deadline: September 4, 2024

Notification of acceptance: October 15, 2024

点此提交摘要>>>Submit Abstract>>>

Unlock Your Path to Success: Craft a Winning Abstract in Ten Easy Steps!

Previous WCN abstract reviewers Sabine Karam, Magdalena Madero, and Roberto Pecoits-Filho unveil the secrets to creating an abstract that stands out:

Accepted abstracts will be presented as posters or e-posters at WCN’25 and published in a congress supplement to Kidney International Reports® (KIR).

The presenting author must register for the congress by November 6, 2024, to ensure the abstract’s publication in Kidney International Reports® and for poster presentation.

Check out the instructions below on how to complete your online submission

ABSTRACTS CATEGORIES AND TOPICS

The Kidney Losing Function

1. Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum
2. Acute Kidney Injury – Mechanisms, Experimental Models and Biomarkers
3. Acid-base and Electrolyte Abnormalities in Kidney Disease
4. Other AKI
5. Chronic Kidney Disease Diagnosis, Classification and Progression
6. Chronic Kidney Disease Complications
7. Diabetic Kidney Disease, Drugs and Treatments
8. Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine
9. Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
10. Urologic Disorders – Stones, Nephrocalcinosis
11. Other CKD
12. Haemodialysis, Haemodiafiltration and Vascular Access
13. Kidney Transplantation and Transplant Immunology
14. Peritoneal Dialysis

Better Kidney Health

Tropical Kidney Diseases
Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications
Special Challenges in the Burden and Management of CKD in Developing Countries
Bioethics, Supportive/Palliative Care and Quality of Life in Kidney Failure
Other KF (Kidney Failure)
Artificial Intelligence and Machine Learning
Covid-19 and The Kidney

The Smart Kidney

Experimental Models- Glomerulonephritis
Clinical Glomerulonephritis
Physiology of Tubular Function and Tubulointerstitial Kidney Disease, Renal Model Systems (Organoids and Kidney on a Chip)
Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
Nephrotic Syndrome

The Interconnected Kidney

Kidney in Pregnancy and Post-Partum
Cancer Therapy And Kidney Disease
Renal and Electrolyte Manifestation of Onconephrology
Vascular Biology and Endothelial Function
Essential Hypertension and Renovascular Kidney Disease
Epidemiology, Outcomes and Health Services Research in Dialysis

Education

Training
Social media
Curriculum
Online learning

Late Breaking Clinical Trials

Late breaking clinical trials

INSTRUCTIONS FOR COMPLETING YOUR SUBMISSION

Abstract requirements:

Character count: You may use up to 3,400 characters. Spaces are included in the character count (tables and graphs do not count as characters if inserted as an image). Abstract authors/co-authors’ names, affiliations, and keywords do not count towards the 3,400-character allowance.
Abstracts follow a structured format of introduction, methods, results, and conclusion sections. Tables, graphs, and pictures may be included (tables and graphs do not count as characters if inserted as an image).
Images must be in JPEG or PNG format (uploaded images cannot exceed 640w x 480h pixels and 1.5 Megabytes).
Case reports that present novel hypotheses, pathologies, treatments, or ethical issues are welcome. However, they are only likely to be selected if the originality is highlighted effectively.
Encore abstracts are permissible if both the initial and subsequent conferences allow it. Authors must declare this at the end of the abstract as follows: ‘This abstract was also submitted for the (insert meeting title) congress.’ By submitting, the authors confirm that the organizers of the previous meeting will allow re-submission.
Declaration of generative AI in scientific writing: authors must disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their abstract, in a new section entitled ‘Declaration of Generative AI and AI-assisted technologies in the writing process’. See below accordion for all information.
The maximum number of abstract co-authors that can be listed in an abstract is 15.
Please check carefully for typographical errors, misspelled words, misused hyphens, etc. Please also check that your abstract title is correct.
Abstracts must be submitted in English.

Submission conditions:

Accepted abstracts will be published online in Kidney International Reports®. No printed abstract book will be produced.

Presenting authors must register for the congress by November 6, 2024, to have their abstract published as described above and to have a poster presentation at the congress. Abstract presenters must register using the same email, if they fail to do so and do not communicate the change of email to the Abstract team, the abstract might not be published in Kidney International Reports® or presented onsite. WCN organizers will not be held responsible for non-publication.

If the presenting author cannot present the abstract, a co-author may do so, provided they are registered for the congress. In this case, the original presenting author must communicate the presenting author change to the Abstract team (abstractswcn@theisn.org) to confirm that the new presenting author is registered. Failure to do so will result in the withdrawal of the abstract.

A non-refundable handling fee of 40 USD is charged per submitted abstract. When submitting the abstract, the handling fee must be paid by credit card (American Express, MasterCard, or Visa). Payment by bank transfer is not possible. Abstract handling fees are waived only for submitters from low-income countries as defined by World Bank income groups listed here. The handling fee for late-breaking clinical trial abstracts is 100 USD and is not waived for submitters from low-income countries.

Once submitted, abstracts cannot be changed or withdrawn.

All copyrights are assigned to the ISN.

All submitted abstracts will be considered for a poster presentation.

ISN Young Nephrologists Awards: The ISN offers presenting authors under 40 the opportunity to apply for two Young Nephrologists Awards. These awards will cover travel and accommodation costs for attending the congress. Each winner will have an 8-minute oral abstract presentation during a session at the congress. Applications for the awards are only possible during the online abstract submission process.

Organ trafficking and tourism ethics compliance: Scientific studies and clinical activities must be performed in keeping with the ethical principles outlined in the Declaration of Istanbul on Organ Trafficking and Transplant Tourism. By submitting an abstract, you state that you have not violated any aspect of the Declaration or associated consensus statements on live donation and research on human subjects.

Post-submission:

After submitting your abstract, you will receive a confirmation email within two business days. If the email does not appear, please check your spam folder.

If you submit your abstract on the last day of submission (September 4, 2024) and you do not receive confirmation within 48 hours, please email abstractswcn@theisn.org to make sure your abstract has been received.

Authors of accepted abstracts will be notified by email on October 15, 2024

LATE-BREAKING ABSTRACTS

Late-breaking abstracts cover ground-breaking data that would not otherwise have been presented at WCN’25. If such data are available after the regular abstract deadline, the Scientific Program Working Group will still consider it for presentation.

Late-breaking abstracts describe the latest advances, trial data, and results that have not been previously published or presented and highlight novel and practice-changing studies.

The call for late-breaking abstracts is not an extension of the general submission deadline.

Late-breaking abstract submitters are required to submit a ‘place holder’ abstract during the regular submission period (deadline September 4, 2024). For further information on updating your abstract, please see “Post-Submission” section below.

Preparing a Late-breaking Abstract Submission:

Abstract Requirements:

Late-breaking abstracts should follow the standard abstract structure: introduction, methods, results and conclusions.
Late-breaking abstracts should highlight novel and practice-changing studies.

Submission Conditions:

Late-breaking abstracts will only be considered if a placeholder abstract is submitted during the regular abstract submission period (deadline September 4, 2024). To submit an abstract, please log in to your congress profile and go to “Late-breaking Clinical Trial Abstract(s).”
A non-refundable handling fee of 100 USD will be charged per abstract submitted in this category. This fee is not waived for applications from low-income countries.
Late-breaking abstracts will be considered for potential oral presentation in one of the sessions at WCN’25.
The call for late-breaking abstracts is not an extension of the submission deadline.

Post Submission:

Updating an abstract Please send a letter of intent to abstractswcn@theisn.org no later than November 6, 2024.
The abstract submission portal will temporarily re-open until November 6, 2024 for authors to make updates.

WCN2025 注册费：